A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing
Condition(s):Metastatic Bladder Cancer; Metastatic Urothelial CarcinomaLast Updated:November 28, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Metastatic Bladder Cancer; Metastatic Urothelial CarcinomaLast Updated:November 28, 2023Recruiting
Condition(s):Breast NeoplasmsLast Updated:June 4, 2019Recruiting
Condition(s):Metastatic Colorectal CancerLast Updated:November 18, 2023Active, not recruiting
Condition(s):Colorectal Cancer; ctDNA; SurveillanceLast Updated:February 1, 2018Unknown status
Condition(s):Breast Cancer, Early-OnsetLast Updated:November 15, 2023Active, not recruiting
Condition(s):Non-small Cell Lung Cancer; Non-small Cell Lung Cancer Stage I; Non-small Cell Lung Cancer Stage II; Non-small Cell Lung Cancer Stage IIILast Updated:February 26, 2024Recruiting
Condition(s):Non Small Cell Lung CancerLast Updated:December 20, 2023Recruiting
Condition(s):NSCLC, Stage IIILast Updated:January 29, 2024Recruiting
Condition(s):Colorectal CancerLast Updated:December 4, 2023Active, not recruiting
Condition(s):Colorectal Cancer Stage II; Colorectal Cancer Stage IIILast Updated:November 23, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.